Education
About Us
Working with TipRanks
Follow Us
Bayer AG (BAYRY)
:BAYRY
Prescriptive Infusion Algorithm, Ab-1005
Parkinson Disease (Disorder)
Phase II
Not Yet Recruiting
Prescriptive Infusion Algorithm (PIA)
Sep 26, 2025
―
Bay 3401016
Alport Syndrome
Phase II
Not Yet Recruiting
BAY3401016; Biomarker Study Alport
Sep 19, 2025
―
Finerenone (Kerendia, Bay94-8862)
Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)
Phase III
Not Yet Recruiting
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Sep 17, 2025
―
Finerenone (Kerendia, Bay94-8862)
Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)
Phase III
Not Yet Recruiting
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Sep 08, 2025
―
Bay 3389934
Sepsis Associated Disseminated Intravascular Coagulation (Dic)
Phase I
Recruiting
A Study to Assess the Safety and Effects of Different Doses of an Investigational Drug, BAY 3389934, in Healthy Japanese Volunteers.
Aug 29, 2025
―
Finerenone (Bay94-8862): Intervention A, Finerenone (Bay94-8862): Intervention B
Healthy Volunteers, Heart Failure With Left Ventricular Ejection Fraction Greater Than Or Equal To 40 Per Cent
Phase I
Completed
A Study to Compare How Much of the Study Treatment Finerenone Gets Into the Blood When the Same Amount is Taken in One and in Two Tablets of Different Strengths in Healthy Male Participants
Aug 06, 2025
―
Sevabertinib
Pharmacokinetics, Hepatic Insufficiency, Liver Diseases, Drug Metabolism
Phase I
Recruiting
A Study Evaluating How Moderate Liver Impairment Affects the Absorption, Distribution, Metabolism, and Elimination of Sevabertinib After a Single Oral Dose
Jul 18, 2025
―
Bay3723113
Obstructive Hypertrophic Cardiomyopathy
Phase III
Recruiting
A Study to Learn More About How Well Aficamten Works in Japanese Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Jun 10, 2025
―
Sham Surgery, Bemdaneprocel
Parkinsons Disease (Pd)
Phase III
Recruiting
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
Apr 07, 2025
―
Bay 3713372
Mtap-Deleted Solid Tumors
Phase I/II
Recruiting
A First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in Participants With MTAP-deleted Solid Tumors
Mar 31, 2025
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Bayer AG (BAYRY) have in its pipeline
BAYRY is currently developing the following drugs: Prescriptive Infusion Algorithm, Ab-1005, Bay 3401016, Finerenone (Kerendia, Bay94-8862). These drug candidates are in various stages of clinical development as the company works toward FDA approval.